Short answer
SANUWAVE Health, Inc. (SNWV) filed an 8-K current report with the SEC on July 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Item 2.02 section contains only incorporation-by-reference disclaimer language.
SANUWAVE Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 section contains only incorporation-by-reference disclaimer language
- No earnings figures, reporting-period results, or operating metrics provided
Item EX-99.1 · Exhibit EX-99.1
- Preliminary Q2 2026 revenue $9.6–$9.8M, exceeding revised guidance ceiling of $9.5M
- Revenue down approximately 3–5% from $10.1M in Q2 2025, signaling continued capital-sales pressure
- Consumable applicator unit sales and revenue reached all-time records, supporting recurring razor-and-blade economics
- Used Ultramist system resales are cannibalizing new capital equipment demand
- Results unaudited and subject to quarter-end close adjustments; final Q2 earnings expected in August
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SANUWAVE Health, Inc. 8-K filings
Get the next SNWV 8-K as it lands
Follow SNWV for push alerts, or ask the research agent what this filing means.